6 Meridian’s Avanos Medical AVNS Stock Holding History

6 Meridian’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-7,766	Closed	-$348K	–	438
2018 Q4	$348K	Sell	7,766 -209	-3%	-$10.9K	0.04%	351
2018 Q3	$546K	Buy	+7,975	New	+$513K	0.06%	199

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

6 Meridian's AVNS Position: Q1 2019 in Review

6 Meridian sold out of Avanos Medical (AVNS) in Q1 2019, closing a stake of 7,766 shares — an estimated $348K sold.

6 Meridian first reported a position in AVNS in Q3 2018 and held it in 2 quarters. The position peaked at $546K in Q3 2018. 338 funds tracked by Wall St. Rank hold AVNS as of Q1 2019.

6 Meridian reported no remaining Avanos Medical position as of Q1 2019 after selling out during the quarter.
6 Meridian sold 7,766 Avanos Medical shares in Q1 2019, an estimated $348K.
6 Meridian first reported a position in Avanos Medical in Q3 2018 and held it in 2 quarters.
6 Meridian's Avanos Medical position peaked at $546K in Q3 2018.
338 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2019.

Based on 6 Meridian's 13F filing for Q1 2019, filed 10 Apr 2019.